Teva to pay $125m after ‘pay-for-delay’ case

10-08-2016

Teva to pay $125m after ‘pay-for-delay’ case

Photo: Tevapharm.com

Teva has settled a dispute with 48 US states after it was found guilty of attempting to pursue ‘pay-for-delay’ agreements with generic drug makers.


Teva, Cephalon, pay-for-delay, patent, Provigil, modafinil, FTC

LSIPR